Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-24-074505
Filing Date
2024-08-30
Accepted
2024-08-30 16:01:03
Documents
1
Period of Report
2024-03-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ownership.html 4  
1 OWNERSHIP DOCUMENT ownership.xml 4 21514
  Complete submission text file 0001213900-24-074505.txt   23153
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Issuer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11 COMMERCE DRIVE FIRST FLOOR CRANFORD NJ 07016
Business Address
Webb Carol (Reporting) CIK: 0001671111 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38174 | Film No.: 241269728